| scholarly article | Q13442814 |
| P50 | author | Marcus O. Muench | Q30470614 |
| P2093 | author name string | Jiaming Wang | |
| Jingwei Yu | |||
| Zhongxia Qi | |||
| Lin Ye | |||
| Noemi Fusaki | |||
| Yuet Wai Kan | |||
| Ashley I Beyer | |||
| P2860 | cites work | A nonviral minicircle vector for deriving human iPS cells | Q41489508 |
| Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells | Q44730049 | ||
| Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells | Q45047169 | ||
| A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies | Q47735198 | ||
| Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. | Q50767115 | ||
| Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. | Q54420423 | ||
| Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells | Q56768636 | ||
| Recurrent copy number variations in human induced pluripotent stem cells | Q84306754 | ||
| Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors | Q28742368 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| Epigenetic memory in induced pluripotent stem cells | Q29547892 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Induced pluripotent stem cells generated without viral integration | Q29614343 | ||
| Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 | ||
| Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency | Q29616797 | ||
| Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 | ||
| Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin | Q29619238 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome | Q30499663 | ||
| Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders | Q33560423 | ||
| A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression | Q33808044 | ||
| Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome | Q33910479 | ||
| Reprogramming of T cells from human peripheral blood | Q34034432 | ||
| Reprogramming of human peripheral blood cells to induced pluripotent stem cells | Q34048915 | ||
| Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats | Q34115609 | ||
| Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells | Q34197304 | ||
| Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | Q34236195 | ||
| Generation of induced pluripotent stem cells using site-specific integration with phage integrase | Q34320340 | ||
| Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors | Q35180600 | ||
| Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? | Q36763610 | ||
| Generation of induced pluripotent stem cells from human blood | Q37209041 | ||
| Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases | Q37239088 | ||
| Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 | ||
| Concise review: Genomic stability of human induced pluripotent stem cells | Q37913263 | ||
| Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures | Q38706487 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 558-566 | |
| P577 | publication date | 2013-07-11 | |
| P1433 | published in | Stem Cells Translational Medicine | Q26842216 |
| P1476 | title | Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors | |
| P478 | volume | 2 |
| Q34560769 | A Comparative View on Human Somatic Cell Sources for iPSC Generation |
| Q35200170 | A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach |
| Q35776875 | A protocol for the identification and validation of novel genetic causes of kidney disease |
| Q34601924 | Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells |
| Q54978842 | Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX. |
| Q92495679 | Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
| Q38372922 | Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine. |
| Q47296243 | Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances |
| Q38995654 | Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery. |
| Q38187494 | Ex vivo production of platelets from stem cells |
| Q35891638 | Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system |
| Q58272766 | Germline Competent Pluripotent Mouse Stem Cells Generated by Plasmid Vectors |
| Q30577389 | Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. |
| Q40387172 | Human neural progenitors derived from integration-free iPSCs for SCI therapy |
| Q26765906 | Induced Pluripotent Stem Cells and Outer Retinal Disease |
| Q38341237 | Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming. |
| Q52585184 | Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications. |
| Q57455701 | Overview of Chemistry, Manufacturing, and Controls (CMC) for Pluripotent Stem Cell-Based Therapies |
| Q27027298 | Progress and challenges in the development of a cell-based therapy for hemophilia A |
| Q35825035 | Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood |
| Q49545028 | Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor |
| Q92994162 | Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector |
| Q34153816 | Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac |
| Q33854184 | Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection |
| Q37223455 | The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice |
| Q45874356 | Viral Vectors, Engineered Cells and the CRISPR Revolution |
Search more.